Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolanda M P Liefhebber

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood Cells, Molecules & Diseases|October 6, 2005
Exosomes contain ubiquitinated proteinsSonja I Buschow, Jolanda M P Liefhebber, Richard Wubbolts, et al.
Journal of Virology|April 14, 2006
Repair and polyadenylation of a naturally occurring hepatitis C virus 3' nontranslated region-shorter variant in selectable replicon cell linesHans C van Leeuwen, Jolanda M P Liefhebber, Willy J M Spaan
The Journal of Biological Chemistry|June 12, 2014
Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virusJolanda M P Liefhebber, Charlotte V Hague, Qifeng Zhang, et al.
Virology Journal|May 27, 2009
Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domainJolanda M P Liefhebber, Bernd W Brandt, Rene Broer, et al.
The Journal of General Virology|November 20, 2009
Characterization of hepatitis C virus NS3 modifications in the context of replicationJolanda M P Liefhebber, Paul J Hensbergen, André M Deelder, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infectionMark W Robinson, Elihu Aranday-Cortes, Derek Gatherer, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Preclinical efficacy and safety of adeno-associated virus 5 alpha-galactosidase: A gene therapy for Fabry diseaseJolanda M P Liefhebber, Giso Brasser, Elisabeth A Spronck, et al.
Molecular Therapy. Nucleic Acids|April 29, 2024
Erratum: Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse modelVanessa Zancanella, Astrid Vallès, Jolanda M P Liefhebber, et al.
Molecular Therapy. Nucleic Acids|May 11, 2023
Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse modelVanessa Zancanella, Astrid Vallès, Jolanda M P Liefhebber, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood Cells, Molecules & Diseases|October 6, 2005
Exosomes contain ubiquitinated proteinsSonja I Buschow, Jolanda M P Liefhebber, Richard Wubbolts, et al.
Journal of Virology|April 14, 2006
Repair and polyadenylation of a naturally occurring hepatitis C virus 3' nontranslated region-shorter variant in selectable replicon cell linesHans C van Leeuwen, Jolanda M P Liefhebber, Willy J M Spaan
The Journal of Biological Chemistry|June 12, 2014
Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virusJolanda M P Liefhebber, Charlotte V Hague, Qifeng Zhang, et al.
Virology Journal|May 27, 2009
Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domainJolanda M P Liefhebber, Bernd W Brandt, Rene Broer, et al.
The Journal of General Virology|November 20, 2009
Characterization of hepatitis C virus NS3 modifications in the context of replicationJolanda M P Liefhebber, Paul J Hensbergen, André M Deelder, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 25, 2015
Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infectionMark W Robinson, Elihu Aranday-Cortes, Derek Gatherer, et al.
Molecular Therapy. Methods & Clinical Development|December 17, 2024
Preclinical efficacy and safety of adeno-associated virus 5 alpha-galactosidase: A gene therapy for Fabry diseaseJolanda M P Liefhebber, Giso Brasser, Elisabeth A Spronck, et al.
Molecular Therapy. Nucleic Acids|April 29, 2024
Erratum: Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse modelVanessa Zancanella, Astrid Vallès, Jolanda M P Liefhebber, et al.
Molecular Therapy. Nucleic Acids|May 11, 2023
Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse modelVanessa Zancanella, Astrid Vallès, Jolanda M P Liefhebber, et al.
Pageof 1